Dr. Nadejda Mincheva Tsankova's lab focuses on understanding and combating glioblastoma, a type of brain tumor known for its aggressive and invasive nature. They investigate the role of specific proteins in tumor migration and aim to develop new therapeutic strategies that could enhance treatment effectiveness for patients. The lab combines advanced techniques in genomics and spatial analysis to identify biomarkers that predict treatment response, which could lead to improved outcomes in glioblastoma patients.

The Miller Lab focuses on developing new human glioma models to enhance precision treatment for brain tumors. They use advanced techniques to understand how these tumors function and resist therapies, helping to create targeted drug strategies. By collaborating with experts in various fields, the lab aims to improve options for patients suffering from gliomas, which are the most common and deadly brain cancer.

Dr. Sharon A Nachman's lab at Johns Hopkins University focuses on improving health outcomes for infants, children, adolescents, and pregnant women affected by HIV and tuberculosis. The lab conducts research through the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, exploring safe, effective treatments and strategies to combat HIV and TB in vulnerable populations. Their efforts aim to establish better health interventions and inform public health policies that can help eliminate these epidemics.

Dr. Charles J Dimitroff’s lab at Florida International University focuses on understanding how certain sugars on melanoma cells affect the progression of the disease. The team investigates specific proteins called galectins that interact with these sugars, which may help in predicting which melanoma cases will worsen. Ultimately, their research aims to identify new biomarkers to enhance treatment options for patients suffering from metastatic melanoma.

Dr. Brian A. Cobb's lab at Case Western Reserve University studies the complex world of glycoproteins, especially how their sugar structures influence immune responses. The team's research focuses on how glycosylation (the addition of sugar molecules to proteins), particularly on antibodies, can be modulated for therapeutic benefits in diseases like autoimmunity and inflammation. By understanding the mechanisms behind these modifications, the lab aims to create new treatments that can better manage inflammatory diseases through targeted therapies.

Dr. Max Tischfield's lab at Rutgers University studies how the brain clears out harmful waste and proteins that accumulate due to aging and diseases like Alzheimer's. They focus on understanding the glymphatic system, which uses cerebrospinal fluid (CSF) to flush out toxins. By exploring a specific ion channel called Piezo1, the lab aims to uncover new therapeutic strategies to improve brain health and cognitive function, especially in older adults.

Dr. Michael G. Goggins' lab at Johns Hopkins University focuses on improving the early detection and screening of pancreatic cancer, particularly for individuals at high genetic risk. The lab conducts multi-center studies to investigate the efficacy of novel blood tests and imaging techniques in identifying pancreatic cancer at an early stage. Their research aims to enhance patient outcomes through timely diagnosis and surveillance methods.

Dr. Ananda W Goldrath's lab at UC San Diego focuses on understanding how T cells, especially memory CD8 T cells, adapt to different tissues in the body to provide effective immunity against infections and cancers. The lab investigates the unique changes in gene expression and metabolism that allow these immune cells to survive and function in various environments, particularly in the small intestine. This research has implications for developing better vaccines and immunotherapies tailored to enhance the immune response in specific tissues.

Dr. Qizhi Gong's lab at UC Davis is focused on understanding how the COVID-19 virus affects the sense of smell, particularly through its impact on specific cells in the olfactory epithelium. The lab investigates the role of sustentacular cells in the immune response to SARS-CoV-2 infection, seeking to unravel why some people experience a loss of smell as a symptom of COVID-19. By exploring these cellular interactions and inflammatory responses, the research aims to provide deeper insights into olfactory dysfunction caused by viral infections.

Dr. Steven L. Gonias's lab focuses on understanding the anti-inflammatory effects of a harmless form of prion protein in the brain, which could lead to new treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. His research explores how this protein interacts with specific cellular receptors to reduce harmful inflammation in brain cells, particularly microglia and astrocytes. By studying these processes in mouse models, the lab aims to develop therapies that enhance the brain's natural defenses against inflammation.

Dr. Jeffrey I. Gordon's lab focuses on understanding how gut microbes influence the health and development of children, particularly those suffering from malnutrition. The lab has developed innovative food formulations designed to improve gut microbiota in undernourished children, which helps enhance their growth and overall health. By studying the relationship between specific dietary components and gut bacteria, they aim to create effective nutritional strategies that promote better developmental outcomes.

Dr. Henk Granzier's lab at the University of Arizona focuses on the giant protein titin and its role in muscle function and stiffness regulation. They investigate how titin interacts with muscle filaments during contraction and how mutations in this protein can lead to muscle diseases. By using mouse models and various experimental techniques, the lab aims to deepen our understanding of muscle mechanics, which could pave the way for new therapies for muscle-related conditions.

Dr. Michael Eldon Greenberg's lab at Harvard Medical School investigates how sensory experiences influence the development of neural circuits, particularly in the visual system. His research focuses on the role of a specific type of brain cell called astrocytes in regulating visual plasticity and the molecular mechanisms tied to learning and memory. By understanding these processes, the lab aims to uncover new approaches to treat conditions such as amblyopia and other neurodevelopmental disorders.

Dr. Matthew Blake Greenblatt's lab focuses on understanding how specific skeletal stem cells can be harnessed to promote limb regeneration and improve skeletal health. His research aims to discover how these stem cells function in both limb and vertebral regeneration. By studying the mechanisms underlying these processes, his lab hopes to develop innovative therapies for patients suffering from limb loss or spinal disorders.

Dr. Alexander Greninger's lab focuses on enhancing the public sharing of viral genomic data, which is essential for developing vaccines and therapies. They are working on an automated system to improve the quality and speed of viral genome annotations, making it easier for researchers to share data related to viruses that significantly impact public health. Their goal is to prepare for future pandemics by ensuring that viral sequencing data is accurately validated and readily accessible.

David Gresham's lab at NYU studies how cells respond to nutrient deprivation and adapt through rapid evolution. They focus on understanding cell quiescence, a state where cells remain inactive but can react to challenges, and how certain genetic changes can lead to rapid adaptations in microbes. This research has implications for improving antifungal treatments and understanding diseases influenced by genetic variation.

Dr. Anthony Griffiths' research lab at the University of Missouri-Columbia focuses on infectious diseases and biocontainment, particularly concerning high-priority pathogens. The lab not only conducts cutting-edge research but also emphasizes the training of future scientists and professionals in dealing with emerging infectious diseases. Using state-of-the-art facilities, the lab aims to develop novel medical countermeasures and improve pandemic preparedness through collaboration and knowledge sharing in the field.

Dr. Howard Gritton's lab at the University of Illinois at Urbana-Champaign focuses on understanding how exposure to certain environmental chemicals, particularly phthalates, impacts brain development and behavior. The research aims to reveal the connections between these exposures and social behavior changes, especially in relation to autism spectrum disorders. By studying animal models, the lab investigates how these chemicals might alter brain connectivity and gene expression tied to social behavior.

Professor Alan D. Grossman and his lab at MIT study how bacteria share and acquire genes through a process called horizontal gene transfer. They focus on understanding the roles of mobile genetic elements, like plasmids and conjugative elements, in bacterial evolution and survival, particularly using Bacillus subtilis as a model organism. The research aims to uncover the interactions between these elements and how they can affect the behavior and characteristics of bacterial populations.

Barry M. Gumbiner's lab at the University of Virginia focuses on understanding how blood vessels regulate their permeability and maintain their structure. The lab studies a specific protein called VE-cadherin that is crucial for the junctions between endothelial cells, which line blood vessels. By investigating the mechanisms that control these junctions, especially during inflammation, the lab seeks to develop new approaches to prevent tissue damage in various diseases associated with excessive blood vessel leakiness.